Adaptimmune nears second approval for TCR-T therapy

Next-gen antibody formats presented at PEGS Europe

Novo Nordisk signs deal for monthly GLP-1 agonist

Transgene and ProBioGen forge partnership

Blue Therapeutics gets financing to push radiotherapies